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OverviewAfter the Genome:
DNA and Human Disease
hypoplasia reported in Cell last month, for example, took
a mere eight years from its initial mapping (Ridanpa¨a¨ et
al., 2001; Figure 1)—researchers now have an invaluable
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tool at their fingertips: the human genome sequence.
The raw sequence deposited nightly by the public ge-
“[The Human Genome Project] is like sending a man to
nome consortium over the past couple of years has
the moon. When you think about it, sending a man to
facilitated the identification of more than 30 disease
the moon is easy, it’s getting him back that’s difficult.
genes, including genes for deafness and epilepsy (Inter-
So I think we now need to get the human genome to
national Human Genome Sequencing Consortium, 2001).
return to work.”
—Sydney Brenner
DNA and Disease
As welcome as these advances undoubtedly are, there
Fifteen years ago, an opportune review in Cell effec- is a major leap between identifying genes for rare mono-
tively signaled a spectacular new chapter in human ge- genic disorders and the susceptibility factors that con-
netics research. Commenting on the exciting discovery tribute to more complex diseases that affect millions of
in quick succession of the genes for three major genetic people around the world (reviewed by Risch, 2000). The
disorders—Duchenne muscular dystrophy, chronic granu- ten reviews and two minireviews appearing in this judi-
lomatous disease, and retinoblastoma—Stuart Orkin ciously timed issue of Cell present a broad picture of
wrote, “A new phase in the application of molecular the current state of analysis in many of the most complex
genetics to the dissection of human inherited disease human disorders, including cardiovascular disease, dia-
has begun” (Orkin, 1986). In all three cases, researchers betes, and obesity. (The subject of cancer, which was
tracked the genes in question guided more by cytoge- comprehensively reviewed in these pages by Hanahan
netic clues than by any profound insights into the func- and Weinberg [2000] will be revisited in appropriate
tion of the corresponding protein. The era of reverse depth later this year.)
genetics (as Orkin put it), subsequently termed posi- As is clear in many of these reviews, there has been
tional cloning, had arrived (Collins, 1992), although Dro- remarkable progress in identifying genetic factors in
sophilists disdainfully insist that they were performing many common disorders, even before the genome was
the same tricks a full decade earlier (Rubin and Lewis, completed, which bodes well for the future. In particular,
2000). insights from studying relatively rare monogenic forms
How times change. With the Human Genome Project
essentially completed five years ahead of the initial pre-
dictions (Davies, 2001), genetics is embarking on an
exciting new chapter—the second half of genetics, one
might say (Crow, 2000), with profound changes in the
ways we gather and analyze information that only a few
people saw coming when the Human Genome Project
officially began (Gilbert, 1991). This month, two teams
unveiled the near-complete 3.2-billion-basepair sequence
of the human genome (International Human Genome
Sequencing Consortium, 2001; Venter et al., 2001). Writ-
ing in Nature, the public genome consortium notes that
“the sequence of the human genome is of interest in
several respects”—a degree of scientific understate-
ment not seen since that other citation classic was dis-
patched to the same journal half a century ago (Watson
and Crick, 1953).
Identifying the entire complement of human genes
heralds an exciting new era of proteomics (reviewed by
Brent, 2000), in which large-scale efforts to determine
three-dimensional protein structures (Burley et al., 1999),
map protein–protein networks (Schwikowski et al.,
2000), and elucidate signaling pathways (reviewed by
Hunter, 2000), will radically transform our understanding
Figure 1. A Limestone Statue of Seneb, a Prominent Member of theof the biology of the cell. But the medical benefit will
Egyptian Royal Household during the Sixth Dynasty, Who May Havebe no less profound. While some researchers are still
Suffered from Cartilage-Hair Hypoplasia
resigned to spending years tediously searching for their
The recently identified gene for this disorder took eight years fromquarry—the identification of the gene for cartilage-hair
mapping to cloning, an arduous procedure that may become obso-
lete in the post-genomic era. (Figure courtesy of the Egyptian Mu-
seum, Cairo.)* E-mail: kdavies@cell.com
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of many complex diseases have greatly advanced our (Kass et al., 1994). The patriarch of the family is esti-
mated to have given rise to some 40,000 Americans, ofunderstanding of the fundamental pathophysiological
processes that go awry in the disease state. Perhaps whom perhaps half have dilated cardiomyopathy.
Recent insights into the molecular causes of suddenno disease area has benefited as much by this approach
as the field of hypertension (Lifton et al., 2001 [this is- death, frequently due to cardiac arrhythmia, have been
no less remarkable. Six genes responsible for long QTsue]). In the past decade or so, mutations in close to
20 genes have been associated with various forms of syndrome have been identified (Keating and Sanguinetti,
2001 [this issue]), including HERG, which codes for thehereditary hyper- and hypotension, prompting the in-
triguing idea that some of these variants are thrifty genes cardiac potassium channel. While almost 100 mutations
have been documented in this channel alone, drug-that provided a selective advantage to our ancestors in
sub-Saharan Africa. While the genes for these Men- induced cases of arrhythmia are also associated with
blockage of HERG, which appears to be susceptibledelian disorders have not revealed major genetic deter-
minants that influence blood pressure in the general because of an unusually spacious inner cavity. This is
one area where pharmacogenetics (Roses, 2000) couldpopulation—at least not so far—they have convincingly
reiterated the role of salt balance in regulating blood have significant benefits to prevent unnecessary expo-
sure of individuals at increased risk of acquired long QTpressure, and suggested several important new drug
targets. syndrome to a wide range of drugs.
In 1960, the future director of the National InstitutesGene-mapping approaches have contributed hand-
somely to advances in diabetes (Saltiel, 2001 [this is- of Health, Donald Fredrickson, examined a young child
with curiously orange tonsils resulting from massivesue]), as evidenced by the discovery of a handful of
genes for Mendelian forms of the disease, notably matu- cholesterol deposition. The child hailed from Tangier
island, a tiny ridge of land off the eastern shore of Mary-rity-onset diabetes of the young (MODY). Even though
MODY accounts for only a small percentage of type 2 land that was first settled 300 years ago. The cause of
this rare recessive disorder, named after the island, wasdiabetes, the disorder still affects millions of people
worldwide. The first hint of success in tracing more com- recently found to be mutations in the ABC A1 cholesterol
efflux transporter, a potentially significant advance inplex forms of type 2 diabetes was reported last year
by Bell and colleagues (Horikawa et al., 2000), based on atherosclerosis research (Glass and Witztum, 2001 [this
issue]). New insights into the regulation of this gene,analyses of Mexican-Americans in Starr County, Texas—
testimony to the potential of using isolated populations coupled with suggestions that more subtle mutations
may be associated with more common inherited varia-to tackle the genetics of complex traits (reviewed by
Sheffield et al., 1998). As admirable as this study was, tions in HDL levels, point to a promising future in this
field. Atherosclerosis is just one of many areas of medi-however, there is still much left unknown about the role
of the putative gene, calpain-10, in the pathophysiology cine that will benefit from further study of the tumor
necrosis factor (TNF) and TNF receptor superfamilyof diabetes.
The stunning upswing in obesity research triggered (Locksley et al., 2001 [this issue]), which provides many
rich examples of the myriad uses that evolution can findby the discovery of leptin by positional cloning in 1994,
is tempered by the fact that one-third of Americans for members of a gene family.
In the midst of all this gratifying progress, it bearsare considered obese—a veritable “epidemic of energy
storage” according to Spiegelman and Flier (2001 [this repeating that gene identification is only the first step.
Despite the discovery of mutations in superoxide dismu-issue]). Leptin mutations have only been described in
a handful of human subjects, but the leptin signaling tase in familial amyotrophic lateral sclerosis (Lou Geh-
rig’s disease) in 1993, there is still only a vague under-pathway features several well-characterized proteins in-
cluding the melanocortin-4 receptor, which is mutated standing of the pathological process, and even poorer
comprehension of the relevance to sporadic forms ofin about 5% of obese subjects in some populations
(Cone, 2000). It will be interesting to see whether ongo- the disease (Julien, 2001 [this issue]). And while the
neurofibromatosis type 1 tumor suppressor gene wasing genetic studies on the Pacific island of Kosrae
(Shmulewitz et al., 2001), where obesity is prevalent, discovered in 1990, and despite a wealth of cleverly
designed studies using chimeric mice, there are stillinject even more excitement into obesity research.
Sudden heart attacks cause about 250,000 deaths in gaps in our understanding of its role in the regulation
of Ras (Cichowski and Jacks, 2001 [this issue]).the United States alone each year, usually with no prior
warning. The first major breakthroughs in the genetics With Homo sapiens, the number of published genome
sequences of free-living organisms is over 40. Most be-of familial cardiomyopathy were reported ten years ago,
with the discovery of mutations in a group of sarcomere long to microbial organisms, a revolution sparked by
the whole-genome shotgun sequencing of Haemophilusproteins in patients with hypertrophic cardiomyopathy
(Seidman and Seidman, 2001 [this issue]). Ten such loci influenzae in 1995 (Fleischmann et al., 1995; reviewed by
Fraser et al., 2000). These genome projects are arguablyare now known. Progress in unravelling the genetics of
familial dilated cardiomyopathy has been slower, in part even more important than the human genome in terms
of providing clues to avert human suffering. Tuberculo-because the disease is less common, more heteroge-
neous, and harder to diagnose. But there has been en- sis, for example, is estimated to infect latently about
one third of the world population, and killing more peoplecouraging progress of late, including the discovery of
mutations in the lamin A/C gene on chromosome 1. The every year. The genome of Mycoplasma tuberculosis
was sequenced in 1998, and is already paying dividendsimpact of these Mendelian disorders can be consider-
able: the lamin locus, for example, was first mapped in a in terms of identifying key genes, notably a handful in-
volved in lipid metabolism, that offer promising thera-large, multigeneration Ohio family of German extraction
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Boudoulas, H., Basson, C.T., Baker, P.B., Cody, R.J., Fishman, M.C.,peutic avenues (Glickman and Jacobs, 2001 [this issue]).
et al. (1994). A gene defect that causes conduction system diseaseFinally, the tragedy of the AIDS pandemic is the subject
and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat.of two minireviews (Malim and Emerman, 2001 [this is-
Genet. 7, 546–551.
sue]; Rowland-Jones et al., 2001 [this issue]) that explore
Keating, M.T., and Sanguinetti, M.C. (2001). Molecular and cellular
the roles of genomic variation in the host and the virus mechanisms of cardiac arrhythmias. Cell 104, this issue, 569–580.
in the disease. Lifton, R.P., Gharavi, A., and Geller, D. (2001). Molecular mecha-
As Sydney Brenner astutely pointed out, the alleged nisms of human hypertension. Cell 104, this issue, 545–556.
similarity between the quest for the human genome and Locksley, R.M., Killeen, N., and Lenardo, M.J. (2001). The TNF and
the race to land a man on the moon is only partially TND-receptor superfamilies: architects in mammalian biology. Cell
104, this issue, 487–501.correct. The true challenge begins now in interpreting
and using this bounty of genetic data. Few people, I Malim, M.H., and Emerman, M. (2001). HIV-1 sequence variation:
drift, shift, and attenuation. Cell 104, this issue, 469–472.suspect, would argue with Craig Venter’s assertion (Ven-
Orkin, S.H. (1986). Reverse genetics and human disease. Cell 47,ter et al., 2001) that the ultimate use of the sequence
845–850.will be “to explain how our minds have come to organize
Ridanpa¨a¨, M., van Eenennaam, H., Pelin, K., Chadwick, R., Johnson,thoughts sufficiently well to investigate our own exis-
C., Yuan, B., vanVenrooij, W., Pruijn, G., Salmela, R., Rockas, S., ettence”—doubtless the topic of a future review issue of
al. (2001). Mutations in the RNA component of Rnase MRP causeCell. But in the short term, we will gladly settle for a
a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104,
new appreciation of the factors in our genomes that 195–203.
prematurely curtail that existence. As was heard on Risch, N. (2000). Searching for genetic determinants in the new
more than one occasion during the run-up to this millennium. Nature 405, 847–856.
month’s historic announcements, “the sequence is just Roses, A. (2000). Pharmacogenetics and the practice of medicine.
the beginning …” Nature 405, 857–865.
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